# Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction

> **NCT01705470** · NA · WITHDRAWN · sponsor: **Tel-Aviv Sourasky Medical Center**

## Conditions studied

- Anemia Treatment Among Patients Suffering From Left Ventricular Systolic Dysfunction

## Interventions

- **DRUG:** furosemide
- **DRUG:** placebo normal saline

## Key facts

- **NCT ID:** NCT01705470
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-10
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI left the medical center, no replacement assigned
- **Last updated:** 2016-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01705470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01705470, "Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01705470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*